By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Gilead Sciences, Inc.

Gilead Sciences, Inc. (GILD)

NASDAQ Currency in USD
$117.86
+$2.61
+2.26%
Last Update: 11 Sept 2025, 20:00
$146.24B
Market Cap
23.48
P/E Ratio (TTM)
2.68%
Forward Dividend Yield
$81.57 - $121.83
52 Week Range

GILD Stock Price Chart

Explore Gilead Sciences, Inc. interactive price chart. Choose custom timeframes to analyze GILD price movements and trends.

GILD Company Profile

Discover essential business fundamentals and corporate details for Gilead Sciences, Inc. (GILD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - General

IPO Date

22 Jan 1992

Employees

17.60K

CEO

Daniel P. O'Day

Description

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

GILD Financial Timeline

Browse a chronological timeline of Gilead Sciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 22 Apr 2026

Upcoming earnings on 9 Feb 2026

Upcoming earnings on 5 Nov 2025

EPS estimate is $2.15, while revenue estimate is $7.41B.

Earnings released on 7 Aug 2025

EPS came in at $2.01 surpassing the estimated $1.96 by +2.55%, while revenue for the quarter reached $7.08B , beating expectations by +1.43%.

Dividend declared on 29 Jul 2025

A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend will be paid on 29 Sept 2025.

Earnings released on 24 Apr 2025

EPS came in at $1.81 surpassing the estimated $1.78 by +1.69%, while revenue for the quarter reached $6.67B , missing expectations by -2.11%.

Dividend declared on 22 Apr 2025

A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 27 Jun 2025.

Earnings released on 11 Feb 2025

EPS came in at $1.90 surpassing the estimated $1.74 by +9.20%, while revenue for the quarter reached $7.57B , beating expectations by +5.82%.

Dividend declared on 11 Feb 2025

A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 28 Mar 2025.

Earnings released on 6 Nov 2024

EPS came in at $2.02 surpassing the estimated $1.53 by +32.03%, while revenue for the quarter reached $7.55B , beating expectations by +7.55%.

Dividend declared on 6 Nov 2024

A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 30 Dec 2024.

Earnings released on 8 Aug 2024

EPS came in at $2.01 surpassing the estimated $1.61 by +24.84%, while revenue for the quarter reached $6.95B , beating expectations by +3.68%.

Dividend declared on 8 Aug 2024

A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 27 Sept 2024.

Earnings released on 25 Apr 2024

EPS came in at -$1.32 surpassing the estimated -$1.49 by +11.41%, while revenue for the quarter reached $6.69B , beating expectations by +5.17%.

Dividend declared on 25 Apr 2024

A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 27 Jun 2024.

Earnings released on 6 Feb 2024

EPS came in at $1.72 falling short of the estimated $1.76 by -2.27%, while revenue for the quarter reached $7.12B , beating expectations by +0.20%.

Dividend declared on 1 Feb 2024

A dividend of $0.77 per share was announced, adjusted to $0.77. The dividend was paid on 28 Mar 2024.

Earnings released on 7 Nov 2023

EPS came in at $2.29 surpassing the estimated $1.91 by +19.90%, while revenue for the quarter reached $7.05B , beating expectations by +9.86%.

Dividend declared on 7 Nov 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 28 Dec 2023.

Earnings released on 3 Aug 2023

EPS came in at $1.34 falling short of the estimated $1.60 by -16.25%, while revenue for the quarter reached $6.60B , beating expectations by +2.19%.

Dividend declared on 3 Aug 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 28 Sept 2023.

Earnings released on 27 Apr 2023

EPS came in at $1.37 falling short of the estimated $1.63 by -15.95%, while revenue for the quarter reached $6.35B , missing expectations by -1.60%.

Dividend declared on 27 Apr 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 29 Jun 2023.

Earnings released on 2 Feb 2023

EPS came in at $1.67 surpassing the estimated $1.50 by +11.33%, while revenue for the quarter reached $7.39B , beating expectations by +11.36%.

Dividend declared on 2 Feb 2023

A dividend of $0.75 per share was announced, adjusted to $0.75. The dividend was paid on 30 Mar 2023.

Earnings released on 27 Oct 2022

EPS came in at $1.90 surpassing the estimated $1.44 by +31.94%, while revenue for the quarter reached $7.04B , beating expectations by +14.87%.

Dividend declared on 27 Oct 2022

A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Dec 2022.

Earnings released on 2 Aug 2022

EPS came in at $1.58 surpassing the estimated $1.51 by +4.64%, while revenue for the quarter reached $6.26B , beating expectations by +6.80%.

Dividend declared on 2 Aug 2022

A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Sept 2022.

Earnings released on 28 Apr 2022

EPS came in at $2.12 surpassing the estimated $1.77 by +19.77%, while revenue for the quarter reached $6.59B , beating expectations by +4.85%.

Dividend declared on 28 Apr 2022

A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 29 Jun 2022.

Earnings released on 1 Feb 2022

EPS came in at $0.69 falling short of the estimated $1.53 by -54.90%, while revenue for the quarter reached $7.24B , beating expectations by +9.51%.

Dividend declared on 1 Feb 2022

A dividend of $0.73 per share was announced, adjusted to $0.73. The dividend was paid on 30 Mar 2022.

Earnings released on 28 Oct 2021

EPS came in at $2.65 surpassing the estimated $1.75 by +51.43%, while revenue for the quarter reached $7.42B , beating expectations by +20.58%.

Dividend declared on 28 Oct 2021

A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 30 Dec 2021.

Earnings released on 29 Jul 2021

EPS came in at $1.87 surpassing the estimated $1.76 by +6.25%, while revenue for the quarter reached $6.22B , meeting expectations.

Dividend declared on 29 Jul 2021

A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 29 Sept 2021.

Earnings released on 29 Apr 2021

EPS came in at $2.08 surpassing the estimated $2.06 by +0.97%, while revenue for the quarter reached $6.42B , missing expectations by -3.90%.

Dividend declared on 27 Apr 2021

A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 29 Jun 2021.

Earnings released on 4 Feb 2021

EPS came in at $2.19 surpassing the estimated $2.15 by +1.86%, while revenue for the quarter reached $7.42B , beating expectations by +10.24%.

Dividend declared on 4 Feb 2021

A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 30 Mar 2021.

Earnings released on 28 Oct 2020

EPS came in at $2.11 surpassing the estimated $1.83 by +15.30%, while revenue for the quarter reached $6.58B , beating expectations by +11.05%.

Dividend declared on 28 Oct 2020

A dividend of $0.68 per share was announced, adjusted to $0.68. The dividend was paid on 30 Dec 2020.

Dividend declared on 30 Jul 2020

A dividend of $0.68 per share was announced, adjusted to $0.68. The dividend was paid on 29 Sept 2020.

GILD Stock Performance

Access detailed GILD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run